PHV-wordings
Search narrowed by
Abacavir/Lamivudine/Zidovudine New
PSUR-outcome
|
07/12/2023
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Abacavir/Lamivudine New
PSUR-outcome
|
07/12/2023
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Abacavir New
PSUR-outcome
|
07/12/2023
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Omega-3-acid ethylester New
PSUR-outcome
|
04/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Ibuprofen, Ibuprofen-Lysine (not indicated in Ductus arteriosus) and Ibuprofen/Caffeine New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Beta-alanine New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Levosalbutamol, Salbutamol New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Etoposide New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Lomustine New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Valproate New
Additional template
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
